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Abstract
Osmotin, a plant protein, specifically binds a seven transmembrane domain receptor-like protein to exert its biological activity
via a RAS2/cAMP signalingpathway. Thereceptor proteinis encoded in the gene ORE20/PHO36 and the mammalian homolog
of PHO36isa receptor forthehumanhormoneadiponectin(ADIPOR1). Moreoverit isknownthatthe osmotin domainI canbe
overlapped to the b-barrel domain of adiponectin. Therefore, these observations and some already existing structural and
biological data open a window on a possible use of the osmotin or of its derivative as adiponectin agonist. We have modelled
the three-dimensional structure of the adiponectin trimer (ADIPOQ), and two ADIPOR1 and PHO36 receptors. Moreover, we
have also modelled the followingcomplexes: ADIPOQ/ADIPOR1,osmotin/PHO36and osmotin/ADIPOR1. Wehavethen shown
the structural determinants of these interactions and their physico-chemical features and analyzed the related interaction
residues involved in the formation of the complexes. The stability of the modelled structures and their complexes was always
evaluated and controlled by molecular dynamics. On the basis of these results a 9 residues osmotin peptide was selected and
its interaction with ADIPOR1 and PHO36 was modelled and analysed in term of energetic stability by molecular dynamics. To
confirm in vivo the molecular modelling data, osmotin has been purified from nicotiana tabacum seeds and its nine residues
peptide synthesized. We have used cultured human synovial fibroblasts that respond to adiponectin by increasing the
expression of IL-6, TNF-alpha and IL-1beta via ADIPOR1. The biological effect on fibroblasts of osmotin and its peptide
derivative has been found similar to that of adiponectin confirming the results found in silico.
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Introduction
Osmotin is a vegetable protein belonging to the pathogenesis-
related (PR)-5 family of plant defense proteins that induces
apoptosis in the yeast [1]. It has been found in many fruits, seeds
and vegetables such as grapes, oats and tomatoes where it plays an
antifungal activity [2]. It induces a programmed cell death in
saccaromyces cerevisiae through RAS2/cAMP [3]. Yun et al. have
shown that changes in the yeast cell wall that enhance toxicity are
induced by osmotin via activation of a mitogen-activated protein
kinase Cascade [4]. The osmotin protein has a specific receptor
membrane encoded by the gene ORE20/PHO36 (YOL002c)
codingfora seventransmembranedomainreceptor-likeprotein[2].
In particular, the product of ORE20/PHO36 specifically binds
osmotinat the plasmamembrane and controls osmotin-induced cell
death via a RAS2 signaling pathway [2]. These observations open
interesting questions since the mammalian homolog of PHO36 is a
receptor for the human hormone adiponectin (ADIPOQ). What is
surprising is that osmotin and adiponectin, the receptor binding
proteins, do not share sequence similarity even if both have a similar
internal beta-barrel domain [5].
However,whatismoreinterestingisthatevenosmotincaninduce
AMP kinase phosphorylation in mammalian C2C12 myocytes via
adiponectin receptors. These experimental observations suggest that
osmotin binds the adiponectin receptor (ADIPOR1) in a cellular
environment, made up of human cells, by activating the same
signaling path of adiponectin [2]. If so, osmotin could be a
polypeptide adiponectin-like with molecular and functional mech-
anisms similar to those exercised by human hormone.
On the basis of this hypothesis we have searched answers to the
following questions: a) What are the structural similarities in the
interaction of osmotin and adiponectin with the adiponectin
receptor (ADIPOR1)? b) Knowing the structural basis of their
interaction with the receptor, is it possible to isolate a biologically
active peptide which mimes the adiponectin binding to ADI-
POR1? We have used some methods of molecular modeling for
searching and having those structural answers able to address
functionally our questions. Therefore, in this paper we report the
3D modeling of the globular domain of the human adiponectin
trimer (ADIPOQ), that of its receptor, ADIPOR1, that binds the
globular domain, and that of PHO36. Moreover, we also modeled
the ADIPOQ/ADIPOR1, osmotin/PHO36 and osmotin/ADI-
POR1 complexes. Then, all the amino acids at the interface in
these complexes were evaluated in order to know the structural
and chemical features of these interaction residues that might be
useful in the drug design involved in the treatment of obesity-
related insulin resistance. Therefore, we have selected a small
osmotin peptide (peptide
OSM) and evaluated its ability to interact
with ADIPOR1 and PHO36. The peptide
OSM/ADIPOR1
complex shows that the peptide is firmly positioned in the same
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interact. Finally, experiments on synovial fibroblasts have shown
that this peptide, as well as the whole osmotin, interacts with
ADIPOR1 by activating the same signaling pathway activated by
the adiponectin. The results, even if at an initial stage, show that
the peptide
OSM can be taken into account as adiponectin-receptor
agonist, once suitably amended to make it enzymes resistant.
Methods
Modelling of human adiponectin trimer
The three-dimensional model of the three human adiponectin
chains (UniProt code: Q15848, region 108–244) was performed by
a comparative modelling strategy using as template structures the
related mouse adiponectin chains (PDB code: 1C3H). Since the
template structure contained two trimers having different loop
conformations among beta-strands, we have used: i) the murine A
and D chains to model the human monomer A, ii) the murine B and
E chains as template for the human monomer B and iii) the murine
C and F chains as template for the human monomer C. The
sequence alignment was made by using CLUSTALW program [6].
The MODELLER9 v5 program [7–8] was used to build 10 full-
atom models of the three adiponectin chains by setting 4.0 A ˚ as root
mean square deviation (RMSD) among initial models and by full
model optimization. To select the best models, we used the ProsaII
program [9] to check the fitness of the sequences relative to the
obtained structures and to assign a scoring function, and the
PROCHECK program [10] to evaluate their stereochemical and
structural packing quality. Cysteine side-chains refinement was
performed by SCAP module of Jackal package [11]. Secondary
structures were assigned by the DSSP program [12]. Search for
structural classification was performed on the CATH database [13].
Secondary structure predictions were performed by Jpred server
[14]. The structure of the human adiponectin trimer was assembled
by superimposing the three best modelled chains of human
monomers to the corresponding murine chains, to obtain the same
relative orientation of the threesubunits. This model wasminimized
by using 500 steps of energy minimization under conjugate gradient
algorithm in order to optimize side chain conformations and avoid
sterical clashes according to the commonly used procedure [15–19].
The ‘‘Protein–Protein Interaction Server’’ [20] and NACCESS
program [21] were used to identify the amino acids at the interface
and to evaluate their solvent accessibility. The presence of putative
H-bonds was calculated with Hbplus program [22] but the putative
salt-bridges were evaluated using the program recently developed
by our group [23]. We have also tried to model adiponectin-
examers and higher polymers by docking methods because in PDB
there are not structures that can be used as template but only the
trimer of mouse adiponectin. However attempts were unsuccessful
from a modeling point ofview because themodels were not sostable
during the molecular dynamics experiments. Since x-ray crystallo-
graphic studies [2] have shown that both proteins share the same
lectin-like domain, as well as the structurally active amino acids
which are present on the outer surface of the adiponectin trimer, we
have decided to use the trimer in our studies. Moreover, we have
modeled only the globular part of ADIPOQ (without the related
collagen part) because our aim was to model its complex with
ADIPOR1, receptor for the globular part.
Modelling of human ADIPOR1 and PHO36
Modeling of the human adiponectin receptor 1 (ADIPOR1),
(UniProt code: Q96A54, region 135–355) was obtained using an
integrated protocol based on the method of fold-recognition and
comparative modeling and already used in our recent paper [24].
In particular, we have searched accurately the template for our
modeling procedure using a database of structurally characterized
families of membrane proteins with 7 helix topology (http://opm.
phar.umich.edu/) as well as a fold recognition program LOOPP
[25]. In this case the solution of fold recognition problems follows
from membrane localization of the receptor and reliable
prediction of 7 membrane alpha-helices. Our research has
evidenced that the structure of archeal (Natronomonas pharaonis)
phototaxis protein rhodopsin II (PDB code: 1GU8) presented
similar lengths of helices and loops between the helices respect to
ADIPOR1 and, thus, suggested that this protein was the correct
template for predicting the three-dimensional structure of
ADIPOR1 by comparative modelling strategy. Moreover, in the
obtained model the loop regions were refined using the LOOPY
module of Jackal package, that appeared to yield the best results in
loop modelling, with models that are on average of 2–8% better
than those generated by other programs [26]. We have also
modeled yeast PHO36 (UniProt code: Q12442, region: 80–300)
using the same procedure described for human ADIPOR1 and as
template the structure of archeal (Natronomonas pharaonis) phototaxis
protein rhodopsin II (PDB code: 1GU8).
Modelling of ADIPOQ/ADIPOR1 and Osmotin/ADIPOR1
complexes
Firstly PatchDock web server [27] was used to model the
ADIPOQ/ADIPOR1 and Osmotin/ADIPOR1 complexes using
the obtained models for ADIPOQ and ADIPOR1 by the
comparative modelling strategy and the crystallographic structure
of Osmotin (PDB code: 1PCV) [5]. This program is a geometry-
based molecular docking algorithm aimed at finding docking
transformations that yield good molecular complementary shape
[28]. Then, flexible refinement and re-ranking of the rigid docking
solution candidates was performed by FiberDock, that accounts
for both backbone and side-chain flexibility [29]. In particular, this
method optimizes the side chain conformations in the interface,
models backbone movements, minimizes the relative orientations
of the molecules and ranks the refined solutions by a binding
energy scoring function [29]. We have chosen FiberDock because
it has been used in last CAPRI experiment up to 40 targets and its
flexible refinement process resulted in a drastic improvement in
the accuracy of predicted complexes [30]. The complexes were
analyzed by the same programs used for the adiponectin trimers
and in other our recent papers [15–19].
Modelling of an osmotin peptide and of its complex with
ADIPOR1
Starting from the osmotin structure we have selected the peptide
CTQGPCGPT, (segment 157–165), that hereafter we will name as
Peptide
OSM. The peptide shows a disulphide bond between Cys 157
and Cys 162 that stabilizes it during the simulations. This structural
feature proved to be important in comparison with all other different
peptides screened from osmotin as well as the same adiponectin and
involved in the interaction surface between osmotin/adiponectin and
ADIPOR1. These peptides were poor ligands from an energetic
point of view probably because of their high flexibilities. The chosen
peptide was subjected to molecular dynamics by GROMACS
software package (v3.3.1) [31] in cubic boxes filled with SPC216
water molecules and GROMOS43a1 was selected as force-field. To
optimize the system, the peptide model was previously subjected to
energy minimization and positional restraints cycles. The simulation
was carried out with periodic boundary conditions by adding sodium
ions in order to have a value of zero as net electrostatic charge of the
system. The bond lengths were constrained by the all atoms LINCS
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electrostatic interactions with a cutoff of 0.9 nm, according to recent
papers [19,24,32]. The simulations were performed at neutral pH
with runs of 10 ns at room temperature (300 K) coupling the system
to an external bath. GROMACS routines were utilized to check the
trajectories and the quality of the simulations. The complex between
Peptide
OSM a n dA D I P O R 1w a sm o d e l e da n da n a l y z e du s i n gt h e
same procedure reported above.
Modelling of Osmotin/PHO36 and osmotin peptide/
PHO36 complexes
Osmotin/PHO36 and Peptide
OSM/PHO36 complexes were
modeled and analyzed using the obtained model for PHO36 by
comparative modelling strategy, the crystallographic structure of
Osmotin (PDB code: 1PCV) [5] and the same procedures
performed for the complexes with ADIPOR1 based on flexible
refinement docking by FiberDock [29–30].
Peptide
OSM synthesis
The solid-phase peptide synthesis by Fmoc chemistry was used to
obtain our peptide (having pI=5.50), combined with the S-
acetamidomethyl protection for cysteines. Rink-amide resin was
used as a solid-phase carrier, and TBTU was used as a coupling
reagent. Piperidine in dimethylformamide (20% solution) was used
to remove the Fmoc group at every step. The coupling and
deprotection reactions were checked by the Kaiser test. Cleavage
from resin and side-chain deprotection were achieved using a
mixture of 82.5% TFA, 5% thioanisole, 5% m-cresol, 5% water,
and 2.5% ethanedithiol). The peptide was analyzed on a reversed-
phase high performance liquid chromatography (HPLC) C18
column and its purity was checked by MALDI-TOF mass
measurements (Voyager-DE Biospectrometry). Disulfide bond was
formed after cleavage and deprotection of the relevant linear
peptide with Cys’ protecting groups. The two side-chains protecting
groups of cysteine were removed at the same time as peptide
cleavage and the disulfide bond was formed using 0.95 equiv. of
2,20-dithiodipyridine (PySSPy) and 1 mM peptide in 0.1% (v/v)
TFA in water at room temperature. The oxidation was completed
after 2 h and the product was purified by preparative RP-HPLC.
The product was identified by MALDI-TOF. The peptide was
poorly soluble in water at low pH. Its solubility increased at higher
pHs and at pH 6.5 was completely soluble. A batch solution
1610
23 M Peptide
OSM,5 610
23 M K-phosphate buffer at pH 7.4
was used through the experiments diluting it each time to the
appropriate concentration. The peptide concentration was deter-
mined by using a molar extinction coefficient at 276 nm of
165 M
21 cm
21 for Cistine as suggested by Pace et al. (1995) [33]
Osmotin purification
Osmotin was purified to homogeneity from Nicotiana Tabacum
seeds. Purification was achieved by using a procedure consisting of
an acid treatment step followed by two chromatography steps,
already reported for an osmotin-like protein from the seeds of
Benincasa hispida [34]. The protein concentration was determined
by using a molar extinction coefficient at 280 nm of
36,650 M
21cm
21 calculated by the known content of Trp
(5690 M
21cm
21), Tyr (1280 M
21cm
21 and Cys (120 M
21cm
21)
present in the sequence [33]. The protein purity was assessed by
SDS-PAGE and proteins stained with Coomassie brilliant blue.
Cell culture
To elucidate in vivo the cellular effects of the osmotin and
Peptide
OSM in comparison with those exerted by adiponectin, we
have examined the IL6, TNF-alpha and IL-1beta profiles from
normal Synovial tissues obtained by arthroscopic biopsy [35,36].
Fresh tissues were minced and digested in a solution of collagenase
and DNase. Isolated fibroblasts were filtered. The cells were grown
on the plastic cell culture dishes in 90% air-10% CO2 in
Dulbecco’s modified Eagle’s medium, high glucose, supplemented
with 10% HI-FBS, 2 mmol/L l-glutamine, 10 mmol/L nonessen-
tial amino acids (Life Technologies, Inc.), 100 U/ml penicillin,
and 100 mg/ml streptomycin sulfate. The purity of the isolated
cells was assessed by flow cytometry (FACS). Fibroblasts were
cultured and expanded in vitro in monolayer. Fibroblasts from
passages four to nine were used for the experiments.
Evaluation of biological activity of adiponectin, osmotin
and Peptide
OSM
Human full-length adiponectin (Catalog no.1065-AP; R&D
Systems) (5 mg/ml), osmotin (5 mg/ml) and peptide (5 mg/ml)
administration was followed by 24 h of incubation at 37uCi na
humidified incubator and separate plates, the media were then
removed and stored at 280uC until assay. IL-6, TNF-alpha and IL-
1beta in the medium were assayed using a multiplex biometric
ELISA-based immunoassay, containing dyed microspheres conjugat-
ed with a monoclonal antibody specific for a target protein and a
procedures already used in our previous article [37]. In particular, the
cytokine concentrations of IL6, TNF-alpha and IL-1beta were
measured using a 27-Plex panel (Bioplex, Bio-Rad Lab., Inc.,
Hercules, CA, USA) able to measure at the same time all the
cytokines. Each reaction was done in triplicate. Briefly, 30 mlo f
medium sample was diluted 1:4 and incubated with antibody-coupled
beads. Complexes were washed, then incubated with biotinylated
detection antibody, and, finally, with streptavidin-phycoerythrin prior
to assessing cytokine concentration titers. Cytokine levels were
determined using a Bio-Plex array reader (Luminex, Austin, TX).
Results
Human adiponectin model
The three-dimensional model of the human adiponectin trimer was
performed, according to the comparative modelling strategy and using
as template structures three murine chains because the sequence
identity percentage between human and mouse proteins was equal to
91%. Figure 1 shows the alignment of an adiponectin monomer in
human and mouse. Starting from this alignment, a set of 10 full-atoms
models was generated for each human monomer. The best models
( s e eT a b l eS 1 )h a dP r o s aZ - s c o r eo f24.7 and 92% of residues were in
most favored regions. These values, compared with those of the
template murine structures, indicated the good quality of models.
Secondary structure predictions made by JPred program agree well
with the adiponectin models obtained by comparative modeling. The
adiponectin monomer (shown in Figure 2A) present 11 beta-strands
organized in an architecture of ‘‘mainly beta sandwich’’ type.
Moreover, the models of human and mouse adiponectin were
compared by structural superimposition as well as in terms of
secondary structures. RMSD values resulted in about 0.25 A ˚ each.
Moreover, the comparison of the secondary structures evidenced that
beta-strands were well conserved along the sequence, with very few
changes. In Figure 2B the model of adiponectin trimer is shown. The
three monomers presented very similar conformations in terms of
secondary structures as in the mouse trimer (PDB code: 1C3H). In
particular, the location and length of beta-strands were equal in the
three monomers. We found very small differences located only in loop
conformations and a mean RMSD value of 0.17 A ˚ was obtained by
structural superimposition of the three human monomers. We have
also evaluated the interactions features between the monomers in two
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small differencesin the valuesof the interface areas,and in the number
of interaction residues, of H-bonds and salt-bridges that depend on
few not conserved residues in two mammalian sequences.
Human ADIPOR1 model
We have modeled ADIPOR1 receptor because it is known to
bind the globular part of ADIPOQ (i.e. without the related collagen
part). The alignment between ADIPOR1 and the template
structure used for the modelling procedure is reported in Figure 3.
The obtained model shows Prosa Z-score of 22.97 and 93.2% of
residues in the most favored regions. These values, compared with
those of the template structure, indicate that our model has a good
energetic and stereo-chemical quality as we have also found in the
adiponectin model. Secondary structure predictions made by
JPRED agree with the obtained structure by comparative
modelling. ADIPOR1 model is composed by seven trans-mem-
brane helices and several intra- and extra-cellular loops character-
istics of all the transmembrane receptors (Figure 4). Comparing the
secondary structures between ADIPOR1 and rhodopsin models it is
evident that the seven transmembrane helices are well conserved
with only few changes in helix lengths (see Figure 3).
PHO36 model
Figure 3 shows the alignment between PHO36 and the template
structure used for the modelling procedure. The obtained model
shows Prosa Z-score of 22.4 and 95.9% of residues in the most
favored regions. It is composed by seven trans-membrane helices
and several intra- and extra-cellular loops characteristics of all the
transmembrane receptors as well as for ADIPOR1 (Figure S1).
Comparing the secondary structures of PHO36, ADIPOR1 and
rhodopsin models it is evident that the seven transmembrane
helices are well conserved with only few changes in helix lengths
(see Figure 3). Moreover, the models of human ADIPOR1 and
yeast PHO36 were also compared by structural superimposition
and an RMSD value of 0.24 A ˚ confirmed that these two receptors
had very similar structures.
Modelling of ADIPOQ/ADIPOR1 and Osmotin/ADIPOR1
complexes
The ADIPOQ/ADIPOR1 complex was modeled (Figure 4A)
and the interaction between the adiponectin and receptor regions
were analyzed in terms of surface (ASA) and residues to the
interface, H-Bonds, salt bridges (Tables 1 and 2). The adiponectin
Figure 1. Alignment of adiponectin monomer A in mouse and human. Secondary structure prediction made by JPred. Amino acids in the
beta-strands are underlined.
doi:10.1371/journal.pone.0016690.g001
Figure 2. 3D model of monomer A and trimer of human adiponectin. The beta-strands are indicated with arrows.
doi:10.1371/journal.pone.0016690.g002
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domain and ADIPOR1 by its extracellular loops. In the best
obtained complex the ADIPOQ and ADIPOR1 chains form 3 H-
bonds and 15 salt bridges. Instead, in the osmotin/ADIPOR1
complex (Figure 4B) the osmotin interacts with ADIPOR1 by 3 H-
bonds and 14 salt bridges. In particular, the osmotin exposes the
amino acids located in beta-strands, helices and loop (Figure S2)
while ADIPOR1 interacts by its extracellular loops as already seen
in the ADIPOQ/ADIPOR1 complex.
Osmotin peptide model and its complex with ADIPOR1
The osmotin/ADIPOR1 complex presents a global architecture
very similar to that shown by the adiponectin/ADIPOR1 complex
(Figure 4A–B). The Peptide
OSM (region 157–165 in the osmotin
Figure 3. Alignment of Rhodopsin, ADIPOR1 and PHO36. Secondary structure predictions made by JPred are reported for ADIPOR1 and
PHO36. Amino acids in the helices are reported in grey but those interacting with the ADIPOQ, osmotin (OSM) and Peptide
OSM in the related
complexes with ADIPOR1 and PHO36are evidenced in bold.
doi:10.1371/journal.pone.0016690.g003
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ADIPOR1 (Table 2). The possible fluctuations of its structure are
reduced by the presence of the disulphide bond as demonstrated
by the short molecular dynamics simulation time. In fact, a stable
state was quickly reached after 3 ns and was constant up to the end
of the dynamics (see Figure S3). In the Peptide
OSM/ADIPOR1
complex the peptide has been found to interact with ADIPOR1 by
3 H-bonds and 4 salt bridge (Table 1 and Figures 4C and 5).
Modelling of Osmotin/PHO36 and Peptide
OSM/PHO36
complexes
The osmotin/PHO36 complex was modeled and evaluated in
terms of surface (ASA) and residues to the interface, H-Bonds, salt
bridges (Figure S1 and Tables 1 and 2). In this complex the
osmotin interacts with PHO36 by 3 H-bonds and 5 salt bridges
and exposes amino acids located in b-strands, helices and loop as
found in the complex with ADIPOR1. In the Peptide
OSM/PHO36
complex the peptide has been found to interact with PHO36 by 2
H-bonds and 2 salt bridges (Figure S1 and Tables 1 and 2).
Biological activity of Osmotin and Peptide
OSM
It has been recently demonstrated that adiponectin acts as an
inducer of inflammatory response by increasing IL-6 production in
human synovial fibroblasts. It was found that adiponectin increases
the expression of IL-6 and ADIPOR1 but not ADIPOR2 [36]. In
general, results suggest that ADIPOR1 is an upstream receptor in
Figure 4. 3D model of three complexes. (A) AdipoQ/ADIPOR1 complex, (B) Osmotin/ADIPOR1 complex and (C) PeptideOSM/ADIPOR1 complex
with a zoom on the Peptide
OSM structure.
doi:10.1371/journal.pone.0016690.g004
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AMPK/p38/IKKab and NF-kB signaling pathway. Moreover,
the same authors also found that the treatment with adiponectin
caused TNF-alpha and IL-1beta release in human synovial
fibroblasts [36]. Therefore, to explore the in vivo effect of osmotin
and its derivative peptide on the adiponectin receptor ADIPOR1,
we have purified osmotin from seeds of Nicotiana Tabacum at
homogeneity according to Shih et al. (2001) [34]. In Figure 6 we
show the SDS-PAGE of the purified fraction of osmotin used for
our experiments. Then the Peptide
OSM was synthesized (see
Methods) and its biological activity on IL-6, TNF-alpha and IL-
1beta was evaluated in cultured synovial fibroblasts in comparison
with adiponectin and whole osmotin. The results, reported in
Table 3, clearly demonstrate that adiponectin as well as osmotin
and Peptide
OSM show a biological activity raising the concentra-
tions of the downstream signaling cytokines activated via
ADIPOR1 as shown by Tang et al. (2007) [36]. Our results also
confirm the work of Narashiman et al. 2005 [2] showing that
osmotin interacts with ADIPOR1 in a manner similar to that
utilized by adiponectin but even the Peptide
OSM shows a similar
effect activating both the same receptor and the signaling pathway.
We have also used two other peptides of nine and eleven residues,
respectively, with random sequences but they did not show any
biological activity in cultured synovial fibroblasts (data not shown).
Even so two unrelated proteins (sperm whale apomyoglobin and
bovine serum albumin (BSA)) were tested with negative results. It
is noteworthy that BSA has been already used as a negative control
to check the binding on unrelated proteins to osmotin receptor [2].
Furthermore, we also observed that the ability of osmotin to
withstand the attack of cellular hydrolytic enzymes decreases
slowly over time during the first 24 hours, as it becomes sufficiently
rapid and substantial if the incubation continues over the
24 hours. The same is true for the peptide. This observation
suggests that the Peptide
OSM, even if biologically active, should be
chemically modified to be used in vivo usefully.
Discussion
In this article, on the basis of experimental data of several
authors [2,5], we have executed molecular modeling studies on
adiponectin and its receptor ADIPOR1, on osmotin, and on the
various complexes possible among them with the aim to have a
detailed knowledge of the interactions involved in the binding
regions and to identify a peptide fragment to use in drug design as
a possible putative adiponectin-receptor agonist. The results have
enabled us to select a peptide fragment from osmotin of 9 amino
acids. The peptide, rather rigid for the presence of a disulfide
bond, showed a good affinity for the adiponectin receptor
(ADIPOR1) in terms of binding energy. The indications obtained
by modeling were put into practice by the synthesis of the peptide
that was tested in vivo on cultured synovial cells together with
osmotin. The biological response of the adiponectin-receptor was
to activate the same signaling pathway enabled by the adiponectin
hormone. Experimental data have demonstrated that the
suppression of ADIPOR1 with small interfering RNA (siRNA)
reduced the increase in fatty-acid oxidation by globular domain of
the adiponectin [38]. Thus, the results regarding the expression or
the suppression of ADIPOR1 support the conclusion that this
protein serves as receptor for globular adiponectin and mediates
increased AMPK, PPAR ligand activities and fatty-acid oxidation
Table 1. Analysis of the ADIPOQ/ADIPOR1, Osmotin/ADIPOR1, Peptide
OSM/ADIPOR1, Osmotin/PHO36, and Peptide
OSM/PHO36
complexes in terms of interface surface area (A ˚2), number of interaction residues, interchain H-bonds and salt bridges evaluated for
each chain.
Chains Interface surface area
Number of interaction
residues Interchain H-bonds Salt brigdes
ADIPOQ (Chain A) 207.1 7 1 4
ADIPOR1 220.48 9 1 4
ADIPOQ (Chain B) 645.45 18 1 5
ADIPOR1 735.89 14 1 5
ADIPOQ (Chain C) 619.43 16 1 6
ADIPOR1 676.42 10 1 6
Osmotin 1068.6 26 3 14
ADIPOR1 1072.92 18 3 14
Peptide
OSM 497.46 9 3 4
ADIPOR1 388.04 10 3 4
Osmotin 683.72 21 3 5
PHO36 679.54 17 3 5
Peptide
OSM 345.06 9 2 2
PHO36 304.38 8 2 2
doi:10.1371/journal.pone.0016690.t001
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have shown that obesity and insulin resistance are accompanied by
decreased adiponectin levels and that adiponectin replacement
under experimental setting is able to diminish both insulin
resistance and atherosclerosis. Therefore the adiponectin and its
receptor represent possible therapeutic targets for the treatment of
obesity-related insulin resistance. According to these data, a
therapeutic strategy for type II diabetes, metabolic syndrome and
cardiovascular disease may include the up-regulation of plasma
adiponectin, the up-regulation of adiponectin receptors or the
development of ADIPORs agonists able to stimulate adiponectin
receptors [39].
Independent results showed that a protein from plants, with no
sequence homology with the human adiponectin, interacts with a
membrane receptor codified by the same type of gene encoding for
the membrane receptor of human adiponectin [5]. Experimental
results of Bressan et al. have also shown that the osmotin activates
molecular mechanisms similar to those activated by the adipo-
nectin binding to its receptor [2]. This makes osmotin a useful
molecule to isolate a peptide that can be, in turn, used as a model
to draw new molecules to be used as adiponectin receptor agonist.
For these reasons we have modeled the complex between
ADIPOQ and ADIPOR1 (Figure 4A) and analyzed also the
physical-chemical properties of ADIPOQ and ADIPOR1 residues
present in the interaction regions (Table 2). These two proteins
expose both negatively and positively charged residues in
ADIPOQ (i.e. Lys 169, Arg 221, Asp 170, Asp 187, Asp 227
and Glu 191, Glu 218) and two positively charged residues in
ADIPOR1 (i.e. Lys 170 and Arg 235). These data suggest that the
predominant interaction between the adiponectin and its receptor
is on electrostatic basis. Furthermore, the presence of aromatic
residues (i.e. Tyr 167, Tyr 186, Tye 189, Tyr 225 in ADIPOQ and
Tyr 162, Tyr 229, Phe 163, Phe 228 in ADIPOR1) stabilizes the
interaction between these two proteins and might play an
important role to support the stacking interactions also with
putative agonists and organic compounds. It is also known that
osmotin, a tobacco PR-5 family protein, and adiponectin have
similar structural folds but unrelated sequences [22]. Osmotin
controls the apoptosis in yeast through a homolog of mammalian
adiponectin receptor (PHO36) [2]. The human adiponectin
receptor (ADIPOR1) and the one from yeast PHO36 present a
sequence similarity of about 54% (Figure 3 and Figure S4). X-ray
crystallographic studies revealed that the osmotin is composed of
three domains of which domain I consists of 11 beta-strands,
arranged in the shape of a beta-sandwich, domain II consists of
several loops extending from domain I and stabilized by four
disulfide bonds and domain III consists of a small loop with two
disulfide bonds (Figure S5) [5]. In particular, the domain I
overlaps with the adiponectin, suggesting that the two proteins
share the lectin-like structural domain even if they do not show
sequence similarity. Interestingly, it has been shown that the
osmotin can activate AMP kinase in C2C12 myocytes [2] and the
suppression of ADIPORs expression by siRNA markedly reduced
phosphorylation of AMP kinase induced by osmotin. These data
suggested that the osmotin activates AMP kinase via ADIPORs in
mammalian C2C12 myocytes [2]. Whether the beneficial effects of
adiponectin can be induced by osmotin is currently unknown.
Therefore, we have also modeled the complex between osmotin
and ADIPOR1 (Figure 4B). In this complex the osmotin exposes
three positively charged residues (i.e. 3 Lys) and three negatively
charged residues (i.e. 3 Asp) but ADIPOR1 exposes the same loop
regions and the same charged residues evidenced in the
ADIPOQ/ADIPOR1 complex (Table 2). Moreover, also in this
complex the presence of aromatic residues (i.e. Tyr and Phe)
stabilizes the interaction between these two proteins.
When the osmotin/ADIPOR1 and ADIPOQ/ADIPOR1 com-
plexes are compared with superimposed ADIPOR1 receptors, the
lectin domains of osmotin and of ADIPOQ are not in the same
Table 2. List of interaction residues in ADIPOQ/ADIPOR1, Osmotin/ADIPOR1, Peptide
OSM/ADIPOR1, Osmotin/PHO36, and
Peptide
OSM/PHO36 complexes.
Peptide Residue
ADIPOQ (Chain A) Asp 170, Tyr 186, Gln 188, Tyr 189, Gln 190, Glu 191, Asn 192
ADIPOQ (Chain B) Lys 169, Asp 170, Tyr 186, Asp 187, Gln 188, Tyr 189, Gln 190, Glu 191, Asn 192, Asn 193, Glu 218, Arg 221, Asn 222, Gly 223,
Leu 224, Tyr 225, Ala 226, Asp 227
ADIPOQ (Chain C) Tyr 167, Lys 169, Asp 170, Tyr 186, Gln 188, Tyr 189, Gln 190, Glu 191, Asn 192, Asn 193, Val 194, Glu 218, Arg 221, Gly 223,
Leu 224, Ala 226
ADIPOR1 Met 161, Tyr 162, Phe 163, Met 164, Ala 165, Pro 166, Leu 167, Gln 168, Lys 170, Val 171, Phe 228, Tyr 229, Cys 230, Ser 231,
Gln 233, Pro 234, Arg 235, Val 297, Gly 298, Gly 354, Val 355
Osmotin Gly 118, Lys 119, Cys 157, Thr 158, Gln 159, Gly 160, Pro 161, Cys 162, Gly 163, Pro 164, Thr 165, Phe 166, Lys 169, Lys 172,
Gln 173, Asp 177, Tyr 179, Tyr 181, Pro 182, Asp 184, Asp 185, Pro 186, Thr 187, Thr 189, Phe 190, Thr 191
ADIPOR1 Tyr 162, Met 164, Ala 165, Pro 166, Leu 167, Lys 170, Val 171, Phe 228, Tyr 229, Cys 230, Ser 231, Gln 233, Pro 234, Arg 235,
Val 297, Gly 298, Gly 354, Val 355
Peptide
OSM Cys 157, Thr 158, Gln 159, Gly 160, Pro 161, Cys 162, Gly 163, Pro 164, Thr 165
ADIPOR1 Tyr 162, Met 164, Ala 165, Pro 166, Lys 170, Val 171, Phe 228, Val 297, Gly 298, Val 355
Osmotin Phe 150, Gly 151, Gln 153, Gln 154, Tyr 155, Cys 157, Thr 158, Gln 159, Gly 160, Pro 161, Cys 162, Gly 163, Pro 164, Thr 165,
Phe 166, Lys 169, Tyr 181, Gln 183, Asp 184, Asp 185, Pro 186
PHO36 Ala 108, Thr 109, Thr 110, Trp 112, His 115, Met 116, Val 117, Tyr 173, Phe 174, Glu 175, Lys 176, Phe 177, Ser 178, Leu 179,
Phe 180, Gln 242, Ile 243
Peptide
OSM Cys 157, Thr 158, Gln 159, Gly 160, Pro 161, Cys 162, Gly 163, Pro 164, Thr 165,
PHO36 Thr 109, Thr 110, Thr 111, Trp 112, Tyr 173, Lys 176, Gln 242, Ile 243
Charged amino acids are reported in bold while aromatics are underlined.
doi:10.1371/journal.pone.0016690.t002
Similarities between Osmotin and Adiponectin
PLoS ONE | www.plosone.org 8 February 2011 | Volume 6 | Issue 2 | e16690orientation (see Figure S6). Likely, this could depend from the
different size of ADIPOQ trimer (about 400 residues) in respect to
osmotin (205 residues). However, from the comparison between the
two osmotin/ADIPOR1 and ADIPOQ/ADIPOR1 complexes, it is
evident that the structural determinants of these interactions are
very similar. In fact, the interaction regions of osmotin and
ADIPOQ are almost completely superposed (see Figure S7), the
presence of charged and aromatic residues at the interface is
conserved in the two proteins, and the number of H-bonds with
ADIPOR1 is exactly the same (Table 1). Also, both osmotin and
ADIPOQ show a similar affinity for ADIPOR1 in terms of binding
energy [40], as shown in Figure S8. Therefore, we think that all
these evaluations indicate that osmotin monomer surface mimics
ADIPOQ trimer surface in the context of receptor binding.
Comparing the Osmotin/PHO36 and Osmotin/ADIPOR1
complexes one can evidence that ADIPOR1 presents at the
interface two positively charged residues (i.e. one Lys and one
Arg) whereas PHO36 both positively (i.e. Lys) and negatively (i.e.
Glu) charged residues. Moreover, the osmotin exposes a positively
charged residue (Lys 169) and two negatively charged residues (Asp
184 and Asp 185) in the Osmotin/PHO36 complex, but at the
interface in Osmotin/ADIPOR1 complex there are three positively
and three negatively charged residues, as reported above. Even in
these complexes interactions are stabilized by many aromatic
residues (see Table 2). This highlights that the structural
Figure 5. Details of Pept
OSM - ADIPOR1 interaction. The peptide is reported by stick representation and yellow labels. The interaction residues
of ADIPOR1 are shown by lines and white labels.
doi:10.1371/journal.pone.0016690.g005
Figure 6. SDS-PAGE analysis of osmotin purified according to
Shih et al. (2001) [34]. A. Molecular mass marker (LMW, Amersham
Pharmacia Biotech); B. Protein is indicated by arrow. The gels were
stained with Coomassie brilliant blue.
doi:10.1371/journal.pone.0016690.g006
Table 3. Effect of adiponectin, osmotin and peptide
osm on
human synovial fibroblasts.
basal Adiponectin Osmotin Peptide
OSM
IL6 (pg/mL) 32661 1 0 616 95616 89616
IL-1beta (pg/mL) 62611 163618 141618 130618
TNF-alpha (pg/mL) 51681 0 5 616 92616 86614
doi:10.1371/journal.pone.0016690.t003
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complexes are quite conserved between PHO36 and ADIPOR1
andthatosmotininteractswith ADIPOR1evenmore thanPHO36,
as shown from a higher number of salt bridges (14 in Osmotin/
ADIPOR1 and 5 in Osmotin/PHO36). In fact, osmotin shows for
ADIPOR1 thehighestaffinityintermsofbindingenergy(seeFigure
S8) as well as the highest value of interface surface area (A ˚ 2)a n do f
interaction residues.
All these results evidence that: i) the interaction regions are
conserved in the complexes, ii) the interactions are on electrostatic
basis but stabilized also by stacking interactions and iii) these
findings can be used for the development of new ADIPORs
agonists able to stimulate adiponectin receptors.
Since no therapy has yet been developed with adiponectin,
being a novel hormone, we suggest that the osmotin could be used
as a drug design template in therapeutic strategies for the
treatment of obesity-related insulin resistance. Therefore, we have
focused our attention on the osmotin peptide (sequence segment
157–165) that was observed at the interface between osmotin and
ADIPOR1 as well as between osmotin and PHO36 (Figure S2 and
Table 2). This peptide, also indicated as Peptide
OSM, is stabilized
from a disulphide bond that makes rigid its conformation. In fact,
after molecular dynamics simulation, only the C-terminal residues
of this peptide have been subjected to conformational changes
(Figure S3). In the Peptide
OSM/ADIPOR1 complex, the receptor
exposes the same loops and the same positively charged residues
(i.e. Lys 170 and Arg 235) evidenced in the other two complexes,
i.e., ADIPOQ/ADIPOR1 and Osmotin/ADIPOR1 (Table 2).
We have also modeled the complex between Peptide
OSM and
PHO36, where we have found that the receptor exposes only Lys
176 whereas in the Osmotin/PHO36 complex also Glu 175 was
involved in an interaction at the interface. However, both the
Peptide
OSM and the whole osmotin show higher affinity for
ADIPOR1 than for PHO36 (see Figure S8) with higher values of
interface surface area (A ˚ 2), of number of interaction residues, of H-
bonds, and of salt bridges, too (see Tables 1 and 2).
To support the conclusion reached by our in silico modeling, we
have purified osmotin and synthesized the Peptide
OSM. Afterward
we have compared the in vivo effect of adiponectin, osmotin and
Peptide
OSM on cellular cultures of synovial fibroblasts which are
known to be specifically stimulated through the signaling
downstream pathway of the ADIPOR1 receptor each time it is
bound to the adiponectin. Our in vivo results demonstrate that both
osmotin and Peptide
OSM interact with this same receptor by
triggering the same specific pathway of adiponectin with the same
final products, i.e., IL-6, TNF-alpha and IL-1beta, as already
shown by Tang et al. (2007) [36]. The consideration that osmotin
and adiponectin show related folds, although they do not share
similar sequences, and that their similar structural behaviour in
silico shows similar cellular effects in vivo, is surprising because, in
general, an interaction requires that interacting residues be in
clearly complementary sequence positions. This requires that the
two structures must also predispose these interacting residues at a
suitable distance and well-placed for an efficient interaction. In this
case we have two similarly structured proteins with different
sequences that interact with the same region of a third part
(ADIPOR1) by triggering the same cellular process. Osmotin is
not evolutively adapted to interact with ADIPOR1, therefore, we
have only two choices: a) the osmotin structure is so flexible to
adapt its sequence to the same ADIPOR1 region where
adiponectin interacts too; b) the outer ADIPOR1 region is so
flexible to adapt itself to different ligands structurally similar.
Answer and possible explanation can be given on the basis of some
of our recent observations. In fact, we have found that the outer
loops and/or segments of numerous cytokine receptors have
shown, by the consensus of eight different predictors and charge-
hydrophobicity graphs, a consistent and abundant presence of
intrinsically disordered structural stretches [41]. This finding
opens a gleam on the binding ability of these receptors to different
ligands [42] because of their very flexible and charged structures
very prone to adapt to various structurally unrelated ligands. This
idea suggests that the pleiotropy often attributed to cytokine
receptors may be not always caused by a defective receptor that
loses or misinterprets a signal but also by receptors that may have
multiple ligands, although structurally unrelated, because of their
peculiar structural properties due to the presence of intrinsically
unordered regions. Because the peptide
OSM is structurally stable
and structurally rather rigid with a good affinity to the ADIPOR1
receptor and correctly located to mimic the adiponectin binding,
at the moment it represents, at best of our knowledge, the only
good model of adiponectin agonist in vitro. Another similarly
located peptide from adiponectin resulted very flexible and thus
with lower affinity (data not shown).
Moreover, the peptide
OSM is quite conserved in the family of
the thaumatin-like proteins; in fact, its sequence has an identity
percentage of about 73% in respect to thaumatin-like proteins of
other species (i.e. Cicer aretinum, Vitis Vinifera, Ficus penile, Olea
europaea, etc.). In the literature no mention was found about an
effect on ADIPOR1 exerted by other members of thaumatin-like
proteins. However, a comparative analysis should be made on
these proteins to study their putative role on the binding with
ADIPOR1 but this is outside the aim of this paper.
In this work, we suggest that the Peptide
OSM could be used,
opportunely modified to overcome difficulties in generating
biologically active molecules, as a drug design template for the
treatment of obesity-related insulin resistance. However, this study
also raises questions about the role of this plant protein for the
human health. No studies have been performed to assess if and
how the osmotin affects the human health. This protein is enough
stable and resistant to acidity and enzymes and thus might
circulate through the body as peptides and/or interacting
molecule by considering that it is present in many edible fruits
and vegetables. In general, we have only a poor knowledge of the
biologically active compounds in the foods. Our finding that an
osmotin peptide, structurally very stable, is able to mimic the
adiponectin, raises the question whether the osmotin could play
any role in the health benefits attributed to diets high in fruits and
vegetables. However this is another problem that will need
different approaches to be studied.
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Figure S1 3D model of two complexes. (A) Osmotin/PHO36
complex with Osmotin in fuchsia and PHO36 in cyan and (B)
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superimposed. 3D model of Osmotin is colored in fuchsia and
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